Post by ICON plc

Real-time clinical trials are moving from concept to reality, led by the FDA’s latest initiative to enable near real-time data sharing and AI-enabled decision-making. But what does this mean in a global regulatory landscape where alignment is far from guaranteed? In our latest regulatory blog, we explore how RTCT could reshape trial design, governance and evidence generation and what sponsors should consider when balancing innovation with global expectations. Read more: https://ow.ly/LI6R50Zclei #ClinicalTrials #RealTimeData #RegulatoryStrategy #DrugDevelopment #AIinPharma #ClinicalResearch #FDA